StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3081% below fair value
$0.83−0.05 (-5.21%)

Close on Nov 17, 2026Market cap $3.99MP/E –Yield –

Sonoma Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Sonoma Pharmaceuticals's enterprise value was $736.39K on Nov 11, 2026, against $2.51M a year earlier. Over the last 5 years it ranged from -$2.96M to $5.31M, with a median of $532.18K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$736.39K-75.7%
2025Dec 31, 2025$3.03M–
2024Dec 31, 2024-$395.13K–
2023Dec 29, 2023-$1.20M-963.1%
2022Dec 30, 2022$139.34K-97.4%
2021Dec 31, 2021$5.31M-55.2%
2020Dec 31, 2020$11.86M+352.6%
2019Dec 31, 2019$2.62M+302.2%
2018Dec 31, 2018$651.54K-95.2%
2017Dec 29, 2017$13.67M-24.2%
2016Dec 30, 2016$18.02M+65.3%
2015Dec 31, 2015$10.90M+24.8%
2014Dec 31, 2014$8.74M-58.4%
2013Dec 31, 2013$20.99M+47.3%
2012Dec 31, 2012$14.25M-47.5%
2011Dec 30, 2011$27.13M–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?